Clinical Trial Update: Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating the PET tracer 18F-FP-DTBZ to measure pancreatic beta cell mass in humans, including healthy volunteers and individuals with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• 18F-FP-DTBZ

Snippet

Sponsor: Columbia University | Conditions: Healthy Volunteers, Diabetes Mellitus, Type 1 | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-07-23